sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets

Buy sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets for Wholesale Order

What is sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets?

Sodium valproate 333 mg and valproic acid 145 mg are combined to form sodium valproate 500 mg controlled release tablets, a pharmaceutical compound classified as an anticonvulsant. This formulation is primarily used in the treatment of epilepsy and bipolar disorder, enhancing therapeutic efficacy through controlled release dynamics.

The synthesis involves advanced chemical processes to ensure high purity and bioavailability, essential for regulatory compliance. Sodium valproate is also relevant in niche applications for neurological research and drug development.

What Are the Applications of sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets?

• Management of epilepsy and seizure disorders.
• Treatment of bipolar disorder as a mood stabilizer.
• Research applications in neuropharmacology.
• Formulation in combination therapies for enhanced efficacy.

Why Choose Pharmint as Your sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets Supplier?

Pharmint provides comprehensive global sourcing capabilities, ensuring consistent supply of sodium valproate 500 mg controlled release tablets. We offer Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) with every order, maintaining regulatory compliance for all our products.

Our bulk availability and streamlined export support offer significant advantages over typical vendors, including reduced lead times and enhanced logistical efficiency.

Storage & Handling Guidelines for sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets

Store sodium valproate tablets in a cool, dry place, away from direct light exposure and moisture. Recommended storage temperature is between 15°C to 25°C. Ensure that the product is kept in its original packaging to maintain integrity, especially for bulk or research-grade material.

Regulatory, Documentation & Export Information

This product is not classified as a controlled precursor and does not require end-use declaration. Available documentation includes COA, MSDS, and Drug Master File (DMF) if applicable, ensuring compliance with regulatory standards for pharmaceutical procurement.

FAQs

Where to Buy sodium valproate 333 mg & valproic acid 145 mg together correspond as sodium valproate 500 mg controlled released tablets for bulk?

You can source sodium valproate controlled release tablets in bulk directly from Pharmint.net, ensuring compliance and quality assurance.

What are the safety measures for handling sodium valproate?

Always use personal protective equipment (PPE) when handling sodium valproate. Follow the safety guidelines provided in the MSDS.

What is the shelf life of sodium valproate controlled release tablets?

The shelf life varies by manufacturer but typically ranges from 2 to 3 years when stored properly. Check the COA for specifics.

Can sodium valproate be used in combination with other medications?

Yes, sodium valproate is often used in conjunction with other medications for enhanced therapeutic effects, especially in epilepsy treatment.

What is the significance of the controlled release formulation?

The controlled release formulation allows for gradual absorption, maintaining therapeutic drug levels in the bloodstream and minimizing side effects.